Five pharmaceutical companies across the globe lead the race in producing the first approved COVID-19 vaccine. Wall Street is likewise on alert for banking on the first company to produce an efficient one.As the battle against the spread of coronavirus outbreak across the world intensifies, many companies are working to put themselves at the forefront in producing viable COVID-19 vaccine.Producing a vaccine for human testing and adoption to address the Coronavirus outbreak remains as crucial...
Read More »At Least 20 Coronavirus Vaccines Are in Progress Globally, WHO Officials Confirm
As the search for COVID-19 vaccines intensifies, there are at least 20 coronavirus vaccines in the pipeline. However, Gilead Sciences (GILD) and Moderna (MRNA), the stocks of the leaders in the race, tumbled as the week came to the end.Coronavirus alias COVID-19 is the virus that has taken the humankind hostage for the past two months. It has led to most biotech companies to push beyond their limits in the search for a vaccine. As a result, the World Health Organization (WHO) officials...
Read More »Coronavirus Vaccine Stock: Gilead Sciences or Moderna?
Let’s have a closer look at Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA) stocks as the companies are working on possible coronavirus vaccine.In the race for a coronavirus vaccine, two horses battle for the lead, Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA). As a result, a lot of speculation on the booming of their stock prices has been in the mainstream media, since the outbreak of the deadly virus.Gilead Sciences is an American public biotech company...
Read More »